The evolving role of alemtuzumab in management of patients with CLL.
Faderl S, Coutré S, Byrd JC, Dearden C, Denes A, Dyer MJ, Gregory SA, Gribben JG, Hillmen P, Keating M, Rosen S, Venugopal P, Rai K.
Faderl S, et al. Among authors: denes a.
Leukemia. 2005 Dec;19(12):2147-52. doi: 10.1038/sj.leu.2403984.
Leukemia. 2005.
PMID: 16239912